ArrowMark Partners

Private Equity

Profile

Headquarters
Denver, Colorado, United States
Investments
2
Companies
1

Capital

Total Deployed
$554M
Lead Rounds
0

Portfolio

1 company
Freenome $1.3B
Private South San Francisco, California, United States

Biotech company developing AI-powered multiomics blood tests for early cancer detection. Its platform analyzes cell-free DNA, methylation patterns, and protein biomarkers from routine blood draws to screen for cancers in their earliest stages. Lead product SimpleScreen targets FDA approval for colorectal cancer screening.

Investment data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.